Grants Funded
Grant applicants for the 2024 cycle requested a total of nearly $3 million dollars. The PSF Study Section Subcommittees of Basic & Translational Research and Clinical Research evaluated more than 100 grant applications on the following topics:
The PSF awarded research grants totaling over $650,000 dollars to support more than 20 plastic surgery research proposals.
ASPS/PSF leadership is committed to continuing to provide high levels of investigator-initiated research support to ensure that plastic surgeons have the needed research resources to be pioneers and innovators in advancing the practice of medicine.
Research Abstracts
Search The PSF database to have easy access to full-text grant abstracts from past PSF-funded research projects 2003 to present. All abstracts are the work of the Principal Investigators and were retrieved from their PSF grant applications. Several different filters may be applied to locate abstracts specific to a particular focus area or PSF funding mechanism.
Prioritizing Preferences for Breast Reconstruction Through Shared Decision-Making
Ronnie Shammas MD
2021
Duke University Medical Center
National Endowment for Plastic Surgery Grant
Breast (Cosmetic / Reconstructive), Economics/Quality/Outcomes
Impact Statement: The product of this research will be an enhanced understanding of how patient preferences for breast reconstruction are influenced by socioeconomic and medical characteristics and will promote the development of a clinically relevant tool that aligns personal preferences with treatment outcomes. These findings have the potential to transform clinical practice by providing surgeons with information about what matters most to each patient seeking reconstructive surgery. In turn, this will enhance shared decision-making with thousands of women facing decisions for breast reconstruction. These findings will be used in a future proposal for extramural funding to assess whether RECONJOINT improves outcomes after breast reconstruction in a randomized controlled trial.
Project Summary: Approximately 40% of breast reconstruction patients experience dissatisfaction due to outcomes of surgery that do not reflect personal treatment preferences. The decisions surrounding breast reconstruction involve trade-offs between multiple simultaneous concerns (i.e. cost, complications, recovery time) to arrive at a treatment that is reflective of personal preferences and values. Thus, it is essential to understand which aspects of breast reconstruction care are most important to each patient when making patient-centered treatment decisions. Conjoint analysis is a unique statistical technique that determines how consumers value different features of a product. This form of preference elicitation shows extraordinary promise in health care to determine how patients value different aspects of treatment. By utilizing conjoint analysis, the relative importance of various treatment attributes can be determined and communicated to the provider to better align treatment preferences with the ultimate outcome. In the context of breast reconstruction, conjoint analysis can determine which attributes of reconstructive surgery are most important to a patient when communicating the shared treatment decision and can be used as part of a shared decision-making tool to facilitate patient-physician communication and individualize breast reconstruction care. Through this research, we will utilize conjoint analysis to assess how patients value different aspects of breast reconstruction and will use these findings to develop a unique shared decision-making tool (RECONJOINT) that will help prioritize patient preferences for breast reconstruction and communicate these preferences to the provider. Our specific aims are the following Aim 1: Design and test the conjoint analysis, Aim 2: Assess patient preferences for breast reconstruction, and Aim 3: Develop RECONJOINT and Clinical Implementation and Analysis. Our central hypothesis is that eliciting treatment preferences with conjoint analysis will enable surgeons to identify treatment strategies most in line with patient preferences and values. Our long-term goal is to develop a clinically relevant tool that will improve patient satisfaction, decision quality, and mitigate regret after breast reconstruction.
